Picture of Translational Development Acquisition logo

TDACU Translational Development Acquisition Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsAdventurousMicro Cap

Annual cashflow statement for Translational Development Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.047-0.486-0.0716.36
Non-Cash Items0.482-0.121-7.31
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.050.003-0.660.336
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.097-0-0.851-0.608
Other Investing Cash Flow Items-174
Purchase of Investments
Cash from Investing Activities-174
Financing Cash Flow Items-0.15106.86
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.09901760.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.002-00.436-0.408